Topic: Biology
Researchers have found a promising way to treat Rett syndrome by increasing levels of a key brain protein. This could help address a rare neurodevelopmental disorder that currently has no cure.
Rett syndrome is a rare genetic condition that affects girls, causing severe impairments in motor skills, speech, and communication. It results from loss-of-function mutations in the MECP2 gene, which regulates many other genes involved in neurological processes. The brain produces two versions of the MeCP2 protein: E1 and E2. Only E1 is associated with Rett syndrome, while E2 is not. Researchers have found that increasing the amount of mutant MeCP2 protein can lead to improvements in survival, movement, and breathing problems in mice.
The study published in Science Translational Medicine describes a potential way to increase levels of this key brain protein by modulating alternative splicing of MECP2. This could provide therapeutic benefit for patients with Rett syndrome. The researchers deleted the Mecp2 exon 2 in mouse models and showed that this up-regulated MeCP2 by 50-60%. They also investigated the consequences of isoform switching in two independent Rett syndrome induced pluripotent stem cell (iPSC)-derived neuron models.
The findings offer early hope for addressing a rare neurodevelopmental disease that currently has no cure. The study's authors are exploring a potential therapeutic strategy using antisense oligonucleotides to promote isoform switching in patients with Rett syndrome who carry partially functioning alleles of MECP2.
Why It Matters
Rett syndrome is a devastating condition that affects many Indian families. This breakthrough could lead to new treatments and hope for those affected by the disorder.
Key Facts
- Rett syndrome is a rare genetic neurodevelopmental condition that causes severe impairments in motor skills, speech, and communication.
- The disorder primarily affects girls; about 1 in 10,000 live births.
- Increasing the amount of mutant MeCP2 protein can lead to improvements in survival, movement, and breathing problems in mice.
- The study published in Science Translational Medicine describes a potential way to increase levels of this key brain protein by modulating alternative splicing of MECP2.
- The researchers deleted the Mecp2 exon 2 in mouse models and showed that this up-regulated MeCP2 by 50-60%
Key Terms
- MECP2
- A gene that regulates many other genes involved in neurological processes
Implications
Rett syndrome is a devastating condition that affects many Indian families. This breakthrough could lead to new treatments and hope for those affected by the disorder.
Source: https://www.sciencedaily.com/releases/2026/03/260306145621.htm
Journal Reference:
- Harini P. Tirumala, Li Wang, Yan Li, Sameer S. Bajikar, Ashley G. Anderson, Wei Wang, Alexander J. Trostle, Mahla Zahabiyon, Aleksandar Bajic, Jean J. Kim, Hu Chen, Zhandong Liu, Huda Y. Zoghbi. Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome. Science Translational Medicine, 2026; 18 (839) DOI: 10.1126/scitranslmed.adq4529
Leave a Comment